R03: Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT04584554
Collaborator
University of North Carolina, Chapel Hill (Other)
31
1
1
7.9
3.9

Study Details

Study Description

Brief Summary

Despite high risks of readmission and complex medical needs, there are no transitional care standards in the U.S. for patients with moderate-to-severe traumatic brain injury (TBI) discharged home from acute hospital care without inpatient rehabilitation. To enhance the standard of TBI care, we will develop and refine a patient- and family-centered TBI transitional care intervention that addresses specific needs and preferences for patients with TBI (age < 65 years) and families and will assess the feasibility, acceptability, and preliminary efficacy of the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: BETTER Transitional Care Intervention
N/A

Detailed Description

Despite high risks of readmission and complex medical needs, there are no transitional care standards in the U.S. for patients with moderate-to-severe traumatic brain injury (TBI). Patients with moderate-to-severe TBI (age < 65 years) discharged home from acute hospital care without inpatient rehabilitation have cognitive, physical, behavioral, and emotional impairments that affect their abilities to independently self-manage their health, wellness, and activities of daily living. Activity limitations often result in increased family involvement for managing the person's care. The complexity of needs combined with the fragmentation of healthcare services creates the perfect storm for mismanaged symptoms, adverse health events, readmissions, and a lower likelihood of return to work and school. Transitional care is defined as actions in the clinical encounter designed to ensure the coordination and continuity of healthcare for patients transferring between different locations or levels of care in close geographic proximity. In other patient groups who experience acute events (e.g., stroke, myocardial infarction), transitional care management has led to improved patient and family outcomes. Although preliminary research shows that patients with TBI and families desire and could benefit from interventions to support the transition from acute hospital care to home, the strength of evidence on this topic is low. TBI transitional care interventions developed to date are ineffective in improving functional outcomes and do not incorporate family needs. Thus, the purpose of our study is to first develop and refine a patient- and family-centered TBI transitional care intervention to support patients with moderate-to-severe TBI and their family caregivers during the transition home from acute hospital care. The intervention will aim to improve quality of life for patients with TBI, reduce strain for their family caregivers, and direct patients and families to appropriate resources and care that is concordant with their health-related goals. Second, we will examine the feasibility and acceptability and assess the preliminary efficacy of the TBI transitional care intervention. The primary outcome will be patient quality of life at 16 weeks post-discharge. This study will also examine secondary outcomes at 16 weeks post-discharge, including family caregiver strain and preparedness for the caregiving role, and patient and family caregiver self-efficacy and healthcare utilization. The new knowledge generated from the proposed research will guide the research team in designing and conducting an NIH R01 implementation-effectiveness clinical trial of the TBI transitional care intervention and will ultimately enhance the standard of care for patients with TBI discharged home from acute hospital care and families

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
15 patient/family dyads will undergo intervention15 patient/family dyads will undergo intervention
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families
Actual Study Start Date :
Feb 17, 2021
Actual Primary Completion Date :
Oct 15, 2021
Actual Study Completion Date :
Oct 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Behavioral: BETTER Transitional Care Intervention
Patient and family will receive pre- and post-discharge support and education from interventionist.

Outcome Measures

Primary Outcome Measures

  1. Change in Short Form-36 (SF-36) [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Quality of Life

Secondary Outcome Measures

  1. Change in Patient Health Questionnaire (PHQ-9) [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Psychiatric status

  2. Change in Self-efficacy for managing chronic conditions [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Self-efficacy

  3. Change in Modified Caregiver Strain Index [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Caregiver strain

  4. Change in Preparedness for Caregiving Scale [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Preparation for Caregiver Role

  5. Change in Health Service Utilization Inventory [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Health service utilization

  6. NeuroQOL measures (short form) [16 weeks post-discharge]

    Functional and cognitive status

  7. Change in Rivermead Post Concussion Questionnaire [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    TBI Symptoms

  8. Change in Satisfaction With Life [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Satisfaction With Life

  9. Change in Interpersonal Processes of Care [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Perceived Discrimination in Health Settings

  10. Change in PTSD Checklist [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Psychiatric Status (PTSD)

  11. Change in Glasgow Outcome Scale-Extended [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Global Outcome

  12. Change in PART-O [Baseline (24-72 hours pre-discharge) and 8- and 16-weeks post-discharge]

    Participation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients: age 18-64 years, diagnosis of mild-moderate TBI based on Glasgow Coma Scale score of 9-14; sufficient cognitive functioning and oral communication skills to participate (as determined by Galveston Orientation and Amnesia Test); set to be discharged directly home from acute hospital care; and has smart phone or computer with internet access.

  • Family caregiver: age 18 years or older, primary caregiver for patient post-discharge (i.e., plans to live in same home as person or have direct contact with person >10 hours/week); and has smart phone or computer with internet access.

Exclusion Criteria:
  • Patients: who do not have a family caregiver who is willing to participate; prior neurological disorder affecting the brain or language or learning disability

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27701

Sponsors and Collaborators

  • Duke University
  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Tolu O Oyesanya, PhD, RN, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT04584554
Other Study ID Numbers:
  • Pro00103181
First Posted:
Oct 14, 2020
Last Update Posted:
Dec 3, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 3, 2021